Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3
Abstract Pancreatic islet transplantation is a promising therapy for patients with type 1 diabetes. However, the duration of long-term graft survival is limited due to inflammatory as well as non-inflammatory processes and routine clinical tests are not suitable to monitor islet survival. 111In-exen...
Guardado en:
Autores principales: | Wael A. Eter, Inge Van der Kroon, Karolina Andralojc, Mijke Buitinga, Stefanie M. A. Willekens, Cathelijne Frielink, Desiree Bos, Lieke Joosten, Otto C. Boerman, Maarten Brom, Martin Gotthardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54496705e6054b69a78f30ff906bdda1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Lieke Joosten, et al.
Publicado: (2017) -
Pancreatic islet macroencapsulation using microwell porous membranes
por: Katarzyna Skrzypek, et al.
Publicado: (2017) -
Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Daphne N. Dorst, et al.
Publicado: (2021) -
Acta No. 111
por: Banco Central de Chile
Publicado: (2019) -
Exendin-4 Exhibits Enhanced Anti-tumor Effects in Diabetic Mice
por: Lan He, et al.
Publicado: (2017)